Onyx ONE: aspirin vs. P2Y12 after 1-month dual antiplatelet therapy for high bleeding risk patients

Watch this video if you want:
- To review the highlights of the Onyx ONE Month DAPT Program
- To listen to commentary on the SAPT late breaker sub-analysis comparing the safety and efficacy of administering aspirin vs. P2Y12 inhibitor
Speaker: Azeem Latib, Elvin Kedhi
Sponsored by Medtronic
This video was recorded for #PCReCourse 2020. View more videos and interviews here:
www.pcronline....